Business Description
Dar Al Dawa Development and Investment
ISIN : JO4101211012
Compare
Compare
Traded in other countries / regions
DADI.Jordan IPO Date
1978-01-01Description
Dar Al Dawa Development and Investment is a pharmaceutical company. The main objectives of the company are to manufacture pharmaceutical, chemical, pharmaceutical, and related products and to import medicines. It offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, dermatology, eye-ear preparations, gastroenterology and metabolism, genitourinary system and sex hormones, musculoskeletal system, nervous system, ophthalmological/otological, and respiratory system, as well as vitamins. The company's geographical segments are Levant and Iraq, Gulf and Yemen, Africa, and Europe and Asia.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.34 | |||||
| Equity-to-Asset | 0.4 | |||||
| Debt-to-Equity | 0.98 | |||||
| Debt-to-EBITDA | 5 | |||||
| Interest Coverage | 1.39 | |||||
| Piotroski F-Score | 9/9 | |||||
| Altman Z-Score | 1.34 | |||||
| Beneish M-Score | -2.85 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.2 | |||||
| 3-Year EBITDA Growth Rate | -32.5 | |||||
| 3-Year EPS without NRI Growth Rate | 24.3 | |||||
| 3-Year FCF Growth Rate | 5.9 | |||||
| 3-Year Book Growth Rate | 1.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 27.6 | |||||
| 9-Day RSI | 28.85 | |||||
| 14-Day RSI | 32.09 | |||||
| 6-1 Month Momentum % | -2.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.12 | |||||
| Quick Ratio | 0.8 | |||||
| Cash Ratio | 0.22 | |||||
| Days Inventory | 380.51 | |||||
| Days Sales Outstanding | 144.52 | |||||
| Days Payable | 307.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.9 | |||||
| Shareholder Yield % | 0.79 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 74.27 | |||||
| Operating Margin % | 7.36 | |||||
| Net Margin % | 4.15 | |||||
| FCF Margin % | 7.48 | |||||
| ROE % | 6.86 | |||||
| ROA % | 2.75 | |||||
| ROIC % | 7.48 | |||||
| 3-Year ROIIC % | -73.59 | |||||
| ROC (Joel Greenblatt) % | 9.98 | |||||
| ROCE % | 13.52 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 14.25 | |||||
| PE Ratio without NRI | 14.25 | |||||
| Shiller PE Ratio | 12.66 | |||||
| PS Ratio | 0.57 | |||||
| PB Ratio | 0.93 | |||||
| Price-to-Tangible-Book | 1.01 | |||||
| Price-to-Free-Cash-Flow | 7.75 | |||||
| Price-to-Operating-Cash-Flow | 5.59 | |||||
| EV-to-EBIT | 11.3 | |||||
| EV-to-EBITDA | 8.06 | |||||
| EV-to-Revenue | 0.98 | |||||
| EV-to-FCF | 13.26 | |||||
| Price-to-Projected-FCF | 0.73 | |||||
| Price-to-Median-PS-Value | 0.87 | |||||
| Price-to-Graham-Number | 0.8 | |||||
| Price-to-Net-Current-Asset-Value | 5.64 | |||||
| Earnings Yield (Greenblatt) % | 8.84 | |||||
| FCF Yield % | 12.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dar Al Dawa Development and Investment Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil JOD) | 74.68 | ||
| EPS (TTM) (JOD) | 0.087 | ||
| Beta | 0 | ||
| Volatility % | 15.48 | ||
| 14-Day RSI | 32.09 | ||
| 14-Day ATR (JOD) | 0.019512 | ||
| 20-Day SMA (JOD) | 1.273 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (JOD) | 1.18 - 1.41 | ||
| Shares Outstanding (Mil) | 35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dar Al Dawa Development and Investment Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dar Al Dawa Development and Investment Stock Events
| Event | Date | Price(JOD) | ||
|---|---|---|---|---|
| No Event Data | ||||
Dar Al Dawa Development and Investment Frequently Asked Questions
What is Dar Al Dawa Development and Investment(AMM:DADI)'s stock price today?
The current price of AMM:DADI is JOD1.24. The 52 week high of AMM:DADI is JOD1.41 and 52 week low is JOD1.18.
When is next earnings date of Dar Al Dawa Development and Investment(AMM:DADI)?
The next earnings date of Dar Al Dawa Development and Investment(AMM:DADI) is .
Does Dar Al Dawa Development and Investment(AMM:DADI) pay dividends? If so, how much?
Dar Al Dawa Development and Investment(AMM:DADI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers